Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 3 of 912345...Last »

McCann Health New York Lands Chief Creative Officer

June Laffey was appointed to the new position of Executive Vice President, Chief Creative Officer, McCann Health New York.

Read More »

China’s illegal opioids enter U.S. through Postal Service gaps: probe

Illegal shipments of the powerful and addictive opioid fentanyl are pouring into the United States by mail from China.

Read More »

Spark licenses blindness gene therapy rights outside U.S.

Spark Therapeutics licensed rights to its breakthrough gene therapy Luxturna outside the United States to Switzerland-based Novartis.

Read More »

AI Biotech Startup XtalPi Scores $15 Million From Google, Tencent and Sequoia

The use of artificial intelligence to address health concerns is a growing field and tech giant Google is backing Chinese company XtalPi Inc. in its goal of using AI to help with drug design.

Read More »

Top Trends Impacting Biopharma Innovation Strategy in 2018

The biopharma industry is perceived to be at a turning point, where companies have the opportunity to meaningfully adapt their innovation strategy and take advantage of major technological advances and new therapeutic modalities.

Read More »

Gates backs Central America malaria elimination plan with $31 million

Philanthropist Bill Gates’ fund is aimed at wiping out the disease in seven of the region’s countries and the Dominican Republic.

Read More »

Novartis says Entresto could become $5 billion a year blockbuster drug

A Novartis executive said the Swiss company’s heart failure medicine Entresto could be used more widely in the future.

Read More »

Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan/MabThera

Pfizer Inc. announced that REFLECTIONS B3281006, a comparative safety and efficacy study of PF-05280586 versus MabThera (rituximab-EU), met its primary endpoint.

Read More »

Europe unlikely to OK Puma breast cancer drug

Puma Biotechnology Inc. said a European regulatory panel indicated it was unlikely to provide a positive opinion on the company’s breast cancer drug.

Read More »

McCann Health Appoints New Global COO

McCann Health announced the appointment of Linda Szyper to the new position of Global Chief Operating Officer.

Read More »

U.S. appeals court upholds ruling invalidating J&J patent on Remicade

A U.S. appeals court upheld a ruling that invalidated a crucial J&J patent on its blockbuster rheumatoid arthritis drug Remicade.

Read More »

Tmunity Banks $100 Million From Gilead and Facebook Billionaire Sean Parker

Tmunity Therapeutics closed on a Series A financing worth $100 million. Syndicate investors included Ping An Ventures, Parker Institute for Cancer Immunotherapy, Gilead Sciences, and Be The Match BioTherapies.

Read More »

Biotech Startup Inks Deal With Pfizer

Rhode Island-based MindImmune Therapeutics forged a research agreement with Pfizer to develop treatments for a number of CNS disorders.

Read More »

Amgen Migraine Drug Wows in Late-Stage Study

Amgen’s migraine drug Aimovig continues to impress with its efficacy in late-stage clinical trials.

Read More »

Drug companies told to do more to tackle ‘superbug’ crisis

Drugmakers’ response to the threat posed by “superbugs” remains patchy even after years of warnings, according to the first analysis of individual companies’ efforts to tackle the antibiotic resistance crisis.

Read More »

ProMIS Neurosciences Lead Product Candidate for Alzheimer’s Disease Shows Potential for Improved Therapeutic Potency Versus Other Amyloid Beta-Directed Antibodies

ProMis Neurosciences Inc. reported further results of its previously announced and ongoing preclinical program for Alzheimer’s disease.

Read More »

J&J takes $13.6 billion charge

Johnson & Johnson said it would take a $13.6 billion charge related to the new U.S. tax law and plans to bring back billions of dollars from overseas immediately.

Read More »

CDC director urges flu vaccinations as pediatric deaths mount

CDC Director Dr. Brenda Fitzgerald urged Americans to get flu shots amid one of the most severe flu seasons in years.

Read More »

Sanofi to Eliminate 400 U.S. Jobs

Paris, France-based Sanofi announced major restructuring involving layoffs. About 400 jobs cut will be in the U.S.

Read More »

Celgene to buy Juno for $9 billion to boost CAR-T expertise

Celgene Corp. announced a $9 billion cash buyout of Juno Therapeutics Inc. as the Summit, N.J.-based company moves to cement its position as a key player in a new range of cancer therapies.

Read More »

Page 3 of 912345...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom